99 related articles for article (PubMed ID: 9548378)
1. Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam.
Nakamura K; Kurasawa M; Tanaka Y
Eur J Pharmacol; 1998 Jan; 342(2-3):127-38. PubMed ID: 9548378
[TBL] [Abstract][Full Text] [Related]
2. Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam.
Nakamura K; Kurasawa M
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):521-8. PubMed ID: 10832606
[TBL] [Abstract][Full Text] [Related]
3. Aniracetam restores motivation reduced by satiation in a choice reaction task in aged rats.
Nakamura K; Kurasawa M
Pharmacol Biochem Behav; 2001 Jan; 68(1):65-9. PubMed ID: 11274709
[TBL] [Abstract][Full Text] [Related]
4. Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats.
Nakamura K; Shirane M; Koshikawa N
Brain Res; 2001 Apr; 897(1-2):82-92. PubMed ID: 11282361
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like effects of aniracetam in aged rats and its mode of action.
Nakamura K; Tanaka Y
Psychopharmacology (Berl); 2001 Nov; 158(2):205-12. PubMed ID: 11702095
[TBL] [Abstract][Full Text] [Related]
6. Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP.
Shirane M; Nakamura K
Brain Res; 2001 Oct; 916(1-2):211-21. PubMed ID: 11597608
[TBL] [Abstract][Full Text] [Related]
7. Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam.
Nakamura K; Shirane M
Eur J Pharmacol; 1999 Sep; 380(2-3):81-9. PubMed ID: 10513566
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of the strychnine-insensitive glycine site antagonist (+)-HA-966 on the hyperactivity and the disruption of prepulse inhibition induced by phencyclidine in rats.
Furuya Y; Kagaya T; Nishizawa Y; Ogura H
Brain Res; 1998 Jan; 781(1-2):227-35. PubMed ID: 9507144
[TBL] [Abstract][Full Text] [Related]
9. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents.
Ugale RR; Hirani K; Morelli M; Chopde CT
Neuropsychopharmacology; 2004 Sep; 29(9):1597-609. PubMed ID: 15100702
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
[TBL] [Abstract][Full Text] [Related]
11. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
[TBL] [Abstract][Full Text] [Related]
12. Behavioral deficits induced by low doses of apomorphine in rats: evidence for a motivational and cognitive dysfunction which discriminates among neuroleptic drugs.
Carnoy P; Ravard S; Wemerman B; Soubrie P; Simon P
Pharmacol Biochem Behav; 1986 Sep; 25(3):503-9. PubMed ID: 2877466
[TBL] [Abstract][Full Text] [Related]
13. Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.
Costall B; Naylor RJ; Nohria V
Eur J Pharmacol; 1978 Jul; 50(1):39-50. PubMed ID: 28233
[TBL] [Abstract][Full Text] [Related]
14. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
15. Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models.
Pereira M; Siba IP; Chioca LR; Correia D; Vital MA; Pizzolatti MG; Santos AR; Andreatini R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1636-44. PubMed ID: 21689712
[TBL] [Abstract][Full Text] [Related]
16. Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats.
Nakamura K; Kurasawa M; Shirane M
Brain Res; 2000 Apr; 862(1-2):266-9. PubMed ID: 10799697
[TBL] [Abstract][Full Text] [Related]
17. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
18. Differential interaction of neuroleptics with apomorphine-induced behavior in rats as a function of changing levels of dopamine receptor stimulation.
Megens AA; Hendrickx HM; Lavreysen H; Langlois X
J Pharmacol Exp Ther; 2013 Dec; 347(3):681-96. PubMed ID: 24071734
[TBL] [Abstract][Full Text] [Related]
19. Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine.
Zhang M; Ballard ME; Unger LV; Haupt A; Gross G; Decker MW; Drescher KU; Rueter LE
Behav Brain Res; 2007 Aug; 182(1):1-11. PubMed ID: 17570538
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: relationship with serotonin and dopamine in the striatum.
Haleem DJ; Ikram H; Haleem MA
Brain Res; 2014 Oct; 1586():73-82. PubMed ID: 25160128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
